Aspire Biopharma Holdings Inc. (ASBP)
NASDAQ · Healthcare
Aspire Biopharma Holdings Inc. Gross Profit 2025–2025
Aspire Biopharma Holdings Inc. annual/quarterly gross profit history and growth rate from 2025 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Aspire Biopharma Holdings Inc. gross profit for the quarter ending March 31, 2026 was 5750.
- Aspire Biopharma Holdings Inc. annual gross profit for 2025 was -116.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aspire Biopharma Holdings Inc. Gross Profit — FAQ
Aspire Biopharma Holdings Inc. (ASBP) gross profit over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is Aspire Biopharma Holdings Inc.'s gross profit?
Aspire Biopharma Holdings Inc. (ASBP) reported gross profit of -$116 for fiscal 2025.
Where can I see ASBP's gross profit history?
The chart and table above show Aspire Biopharma Holdings Inc.'s gross profit by year and by quarter, including the growth rate.